Henry Schein (HSIC) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Henry Schein · Health Care · ref. ETF XLV · 59 calls · price $90.28
What the company does: Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
📈 Henry Schein (HSIC) stock price
$90.28+30.8% over range
Aug 28, 25low $62.03 · high $90.74Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
56% recommend buying · 9 analysts
📊 JPI status : Henry Schein has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 HSIC price target & analyst consensus — price $90.28
The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$112+24.1%
Median target · of 9 targets$94+4.1%
Lowest target · 1 firm of 9$64-29.1%
Current price$90.28
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
556%
$94 ↔ $112
Below
444%
$64 ↔ $90
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (239 calls tested). It aims for $85 (-5.8 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
The 6 reliable analysts
$97.50+8.0 %
The 3 other firms
$82-9.2 %
How to read it: the 6 reliable firms are not filtered by optimism — 5 aim above the price, 1 below, hence their $97.50 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy556%
Hold333%
Sell111%
Strong Sell00%
Go deeper on the analysts
🎯 HSIC price target all
All 59 calls, one by one, with our verdict on each firm.
→ See all 59 targets, analyst by analyst💡 The best analysts on HSIC most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HSIC? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Henry Schein? The JPI assistant answers using our backtest data.
📈 Henry Schein fundamentals: valuation, margins & growth › open the full page
P/E 26.3Net margin 3.0 %Revenue growth +6.7 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 4 %
2023
Rev −2%Profit −23%
2024
Rev +3%Profit −6%
2025
Rev +4%Profit +2%
🏛️ Henry Schein insider buying: who's buying and how much › open the full page
1 insider bought1 buys / 6 mo $692k
🔎 Detailed analyses
🏛️ Which US Congress members hold Henry Schein (HSIC)?
1 Congress member has disclosed HSIC buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Thomas Suozzi 1× · 38%
✅ Historical analyst reliability on HSIC
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Deutsche Bank ↗ | 100% | +18.4% | 2 |
| Stifel ↗ | 100% | +10.9% | 2 |
| Piper Sandler ↗ | 71% | +3.3% | 7 |
| Morgan Stanley ↗ | 71% | -2.1% | 7 |
| Evercore ISI Group ↗ | 67% | +5.7% | 3 |
| B of A Securities ↗ | 67% | -4.8% | 3 |
| JP Morgan ↗ | 50% | +9.6% | 4 |
| Barrington Research ↗ | 47% | +1.8% | 15 |
| Baird ↗ | 40% | +2.0% | 5 |
| Credit Suisse | 40% | -2.1% | 5 |
📊 What $1,000 invested in Henry Schein would be worth › open the full page
In short — $1,000 invested in Henry Schein 10 years ago would be worth $1,346 today, i.e. +3%/yr on average. Best year: 2021 (+16%), worst: 2024 (-9%). Price performance, excluding dividends.
If I'd invested $1,000 in Henry Schein
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,207 | +21% |
| 3 years ago | $1,046 | +5% |
| 5 years ago | $1,249 | +25% |
Return by year (Henry Schein)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +11% | $1,105 (+11%) |
| 2025 | +9% | $1,207 (+21%) |
| 2024 | -9% | $1,103 (+10%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Henry Schein
Loading news…
📋 All analyst calls on HSIC
Filtered on — · ✕ show all
▲ Buy · 🎯$110
Price at call : $89.29 — upside +23%
Today : $90.28 — upside +22%
🎯 on HSIC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
▲ Overweight · 🎯$100
Price at call : $88.13 — upside +13%
Today : $90.28 — upside +11%
🎯 on HSIC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
■ Neutral neutral · not a buy · 🎯$94
Price at call : $88.23 — gap to target +7%
Today : $90.28 — gap to target +4%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Buy · 🎯$112
Price at call : $88.23 — upside +27%
Today : $90.28 — upside +24%
🎯 on HSIC : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Buy · 🎯$100
Price at call : $89.59 — upside +12%
Today : $90.28 — upside +11%
🎯 on HSIC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Piper Sandler ↗
Jul 29, 26
▲ Overweight · 🎯$95
Price at call : $85.17 — upside +12%
Today : $90.28 — upside +5%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
■ Neutral neutral · not a buy · 🎯$89
Price at call : $85.83 — gap to target +4%
Today : $90.28 — gap to target -1%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
BMO Capital ↗
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$85
Price at call : $84.4 — gap to target +1%
Today : $90.28 — gap to target -6%
🎯 on HSIC : no call matured yet · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
See the other 51 calls, newest to oldest
▲ Buy · 🎯$100
Price at call : $80.22 — upside +25%
Today : $90.28 — upside +11%
🎯 on HSIC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
■ Neutral neutral · not a buy · 🎯$85
Price at call : $70.5 — gap to target +21%
Today : $90.28 — gap to target -6%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Neutral neutral · not a buy · 🎯$82
Price at call : $70.5 — gap to target +16%
Today : $90.28 — gap to target -9%
🎯 on HSIC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Morgan Stanley ↗
Apr 24, 26
▼ Underweight · 🎯$64
Price at call : $77.2 — upside -17%
Today : $90.28 — upside -29%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
■ Neutral neutral · not a buy
🎯 on HSIC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 16, 27
matures : Apr 16, 27
▲ Buy · 🎯$100
Price at call : $77.21 — upside +30%
Today : $90.28 — upside +11%
🎯 on HSIC : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$90
Price at call : $75.62 — upside +19%
Today : $90.28 — upside -0%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Barrington Research ↗
Feb 25, 26
▲ Outperform · 🎯$97
Price at call : $81.47 — upside +19%
Today : $90.28 — upside +7%
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
■ Neutral neutral · not a buy · 🎯$87
Price at call : $81.47 — gap to target +7%
Today : $90.28 — gap to target -4%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Overweight · 🎯$92
Price at call : $81.47 — upside +13%
Today : $90.28 — upside +2%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
■ Neutral neutral · not a buy · 🎯$88
Price at call : $81.47 — gap to target +8%
Today : $90.28 — gap to target -3%
🎯 on HSIC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Morgan Stanley ↗
Feb 25, 26
▼ Underweight · 🎯$61
Price at call : $81.47 — upside -25%
Today : $90.28 — upside -32%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Wells Fargo ↗
Feb 25, 26
■ Equal-Weight neutral · not a buy · 🎯$87
Price at call : $81.47 — gap to target +7%
Today : $90.28 — gap to target -4%
🎯 on HSIC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Evercore ISI Group ↗
Feb 25, 26
▲ Outperform · 🎯$100
Price at call : $81.91 — upside +22%
Today : $90.28 — upside +11%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Leerink Partners ↗
Feb 24, 26
■ Market Perform neutral · not a buy · 🎯$87
Price at call : $81.91 — gap to target +6%
Today : $90.28 — gap to target -4%
🎯 on HSIC : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Outperform · 🎯$100
Price at call : $80.57 — upside +24%
Today : $90.28 — upside +11%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
■ Neutral neutral · not a buy · 🎯$81
Price at call : $77.73 — gap to target +4%
Today : $90.28 — gap to target -10%
🎯 on HSIC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
▲ Overweight · 🎯$86
Price at call : $75.88 — upside +13%
Today : $90.28 — upside -5%
🎯 on HSIC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Overweight · 🎯$78
Price at call : $70.06 — upside +11%
Today : $90.28 — upside -14%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Barrington Research ↗
Nov 5, 25
▲ Outperform · 🎯$79
Price at call : $70.06 — upside +13%
Today : $90.28 — upside -12%
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Morgan Stanley ↗
Nov 5, 25
▼ Underweight · 🎯$58
Price at call : $70.06 — upside -17%
Today : $90.28 — upside -36%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Wells Fargo ↗
Nov 5, 25
■ Equal-Weight neutral · not a buy · 🎯$76
Price at call : $70.06 — gap to target +8%
Today : $90.28 — gap to target -16%
🎯 on HSIC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Evercore ISI Group ↗
Nov 5, 25
▲ Outperform · 🎯$90
Price at call : $72.01 — upside +25%
Today : $90.28 — upside -0%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Barrington Research ↗
Oct 22, 25
▲ Outperform · 🎯$78
Price at call : $63.51 — upside +23%
Today : $90.28 — upside -14%
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
Barrington Research ↗
Sep 23, 25
▲ Outperform · 🎯$78
Price at call : $67.75 — upside +15%
Today : $90.28 — upside -14%
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
in progress (365j)
matures : Sep 23, 26
matures : Sep 23, 26
Evercore ISI Group ↗
Aug 26, 25
▲ Outperform · 🎯$83
Price at call : $69.06 — upside +20%
Today : $90.28 — upside -8%
Expected +20% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
+30.9%
stock +31% · XLV +27%
matured Aug 26, 26
▲ Overweight · 🎯$76
Price at call : $65.94 — upside +15%
Today : $90.28 — upside -16%
Expected +15% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
+33.6%
stock +34% · XLV +29%
matured Aug 7, 26
■ Neutral neutral · not a buy · 🎯$70
Price at call : $65.9 — gap to target +6%
Today : $90.28 — gap to target -22%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Aug 6, 26
matures : Aug 6, 26
Evercore ISI Group ↗
Aug 6, 25
■ In-Line neutral · not a buy · 🎯$70
Price at call : $65.9 — gap to target +6%
Today : $90.28 — gap to target -22%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Aug 6, 26
matures : Aug 6, 26
Barrington Research ↗
Aug 6, 25
▲ Outperform · 🎯$78
Price at call : $66.32 — upside +18%
Today : $90.28 — upside -14%
Expected +18% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
+33.0%
stock +33% · XLV +26%
matured Aug 6, 26
■ Hold neutral · not a buy · 🎯$75
Price at call : $71.46 — gap to target +5%
Today : $90.28 — gap to target -17%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jul 25, 26
matures : Jul 25, 26
■ Neutral neutral · not a buy · 🎯$72
Price at call : $70.68 — gap to target +2%
Today : $90.28 — gap to target -20%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 14, 26
matures : Jul 14, 26
Evercore ISI Group ↗
Jul 9, 25
■ In-Line neutral · not a buy · 🎯$78
Price at call : $74.16 — gap to target +5%
Today : $90.28 — gap to target -14%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 9, 26
matures : Jul 9, 26
Wells Fargo ↗
May 6, 25
■ Equal-Weight neutral · not a buy · 🎯$75
Price at call : $66.24 — gap to target +13%
Today : $90.28 — gap to target -17%
🎯 on HSIC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 6, 26
matures : May 6, 26
Barrington Research ↗
May 6, 25
▲ Outperform · 🎯$86
Price at call : $66.24 — upside +30%
Today : $90.28 — upside -5%
Expected +30% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
+9.4%
stock +9% · XLV +8%
matured May 6, 26
Piper Sandler ↗
Apr 30, 25
▲ Overweight · 🎯$77
Price at call : $64.46 — upside +19%
Today : $90.28 — upside -15%
Expected +19% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 46.7% · -1.3% (321 calls)
+14.7%
stock +15% · XLV +6%
matured Apr 30, 26
■ Neutral neutral · not a buy · 🎯$80
Price at call : $72.12 — gap to target +11%
Today : $90.28 — gap to target -11%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 26, 26
matures : Feb 26, 26
Barrington Research ↗
Feb 26, 25
▲ Outperform · 🎯$90
Price at call : $72.55 — upside +24%
Today : $90.28 — upside -0%
Expected +24% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
+12.3%
stock +12% · XLV +6%
matured Feb 26, 26
Wells Fargo ↗
Feb 14, 25
■ Equal-Weight neutral · not a buy · 🎯$80
Price at call : $76 — gap to target +5%
Today : $90.28 — gap to target -11%
🎯 on HSIC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 14, 26
matures : Feb 14, 26
Barrington Research ↗
Jan 30, 25
▲ Outperform · 🎯$90
Price at call : $80.03 — upside +12%
Today : $90.28 — upside -0%
Expected +12% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
-5.7%
stock -6% · XLV +5%
matured Jan 30, 26
■ Hold neutral · not a buy · 🎯$80
Price at call : $74.97 — gap to target +7%
Today : $90.28 — gap to target -11%
🎯 on HSIC : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Jan 23, 26
matures : Jan 23, 26
B of A Securities ↗
Jan 6, 25
▲ Buy · 🎯$84
Price at call : $71.76 — upside +17%
Today : $90.28 — upside -7%
Expected +17% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 48.3% · +2.0% (356 calls)
+9.5%
stock +9% · XLV +14%
matured Jan 6, 26
Barrington Research ↗
Nov 6, 24
▲ Outperform · 🎯$82
Price at call : $69.43 — upside +18%
Today : $90.28 — upside -9%
Expected +18% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
+3.6%
stock +4% · XLV -2%
matured Nov 6, 25
Barrington Research ↗
Sep 20, 24
▲ Outperform · 🎯$82
Price at call : $71.63 — upside +14%
Today : $90.28 — upside -9%
Expected +14% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
-5.2%
stock -5% · XLV -12%
matured Sep 20, 25
Barrington Research ↗
Aug 7, 24
▲ Outperform · 🎯$82
Price at call : $65.77 — upside +25%
Today : $90.28 — upside -9%
Expected +25% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
+0.2%
stock +0% · XLV -12%
matured Aug 7, 25
Barrington Research ↗
Jul 5, 24
▲ Outperform · 🎯$92
Price at call : $64.75 — upside +42%
Today : $90.28 — upside +2%
Expected +42% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
+13.4%
stock +13% · XLV -7%
matured Jul 5, 25
Barrington Research ↗
May 8, 24
▲ Outperform · 🎯$92
Price at call : $73.44 — upside +25%
Today : $90.28 — upside +2%
Expected +25% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
-6.5%
stock -7% · XLV -7%
matured May 8, 25
Barrington Research ↗
Feb 28, 24
▲ Outperform · 🎯$90
Price at call : $76.47 — upside +18%
Today : $90.28 — upside -0%
Expected +18% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
-5.6%
stock -6% · XLV +3%
matured Feb 27, 25
Barrington Research ↗
Nov 14, 23
▲ Outperform · 🎯$82
Price at call : $67.59 — upside +21%
Today : $90.28 — upside -9%
Expected +21% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
-1.6%
stock -2% · XLV +13%
matured Nov 13, 24
Barrington Research ↗
Aug 8, 23
▲ Outperform · 🎯$90
Price at call : $77.42 — upside +16%
Today : $90.28 — upside -0%
Expected +16% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
-12.0%
stock -12% · XLV +11%
matured Aug 7, 24
Barrington Research ↗
May 10, 23
▲ Outperform · 🎯$90
Price at call : $76.93 — upside +17%
Today : $90.28 — upside -0%
Expected +17% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 46% (13 calls matureds) · 📊 on Health : 47.4% · -9.7% (19 calls)
-4.7%
stock -5% · XLV +8%
matured May 9, 24
Frequently asked questions
Should I buy Henry Schein stock?
This isn't buy advice. For Henry Schein, the analyst consensus is "Hold", with an average price target of $94.00 (+4% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Henry Schein). We show the numbers — you decide.
Is it too late to buy Henry Schein? How high can it go?
The most bullish analyst target on Henry Schein is $112 (+24% above today's price); the average is $94.00. That's the upside they see. Check how reliable those analysts have actually been on Henry Schein on our site before trusting it.
Is Henry Schein still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Henry Schein, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Henry Schein? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HSIC (and why hesitate).
What has Henry Schein's past performance been?
Historical returns and a "how much if I had invested" calculator: HSIC performance & returns.
Are insiders buying HSIC stock?
Executives' and large holders' buys and sells, decoded: insider buying on HSIC.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX